Suggestions
Brad Peganoff
Sr. Advisor to President & CSO
Professional Background
Brad Peganoff is a highly accomplished professional with over 20 years of experience in government and corporate relations, predominantly focusing on the life sciences sector. With a profound desire to contribute to the biopharmaceutical industry, Brad is dedicated to advancing research initiatives and developing groundbreaking drugs aimed at alleviating suffering and curing diseases. His impressive career is marked by his commitment to fostering connections between public and private sectors, and he is recognized for his innovative approach to navigating the complex landscape of healthcare and biotechnology.
Brad has held numerous leadership roles that underscore his expertise and influence. As the Senior Advisor to the President & Chief Scientific Officer at mdlogix, he is pivotal in guiding strategic initiatives that focus on leveraging technology to advance healthcare solutions. His extensive experience also includes a prominent role as the Vice President of Business Development at DisposeRx, Inc., where he worked diligently on strategies to promote safe medication disposal, ensuring both public safety and environmental responsibility.
His leadership journey further includes positions as the Vice President of Government & Corporate Affairs at RTI International, where he facilitated partnerships to drive innovation and efficiency in healthcare solutions. Furthermore, as Deputy Director of Government Relations at the Maryland Port Administration, Brad played an instrumental role in bridging communication with government stakeholders, promoting policies that benefitted the life sciences industry. Each role throughout his career has been characterized by a commitment to collaboration, strategic planning, and impactful outcomes.
Education and Achievements
Brad's academic prowess began at Gannon University, where he studied Biology, providing him with a solid foundation in biological sciences. He later advanced his education by pursuing a Master of Science in Biotechnology Enterprise & Regulatory Affairs from The Johns Hopkins University—an institution renowned for its emphasis on healthcare and technology leadership. This combination of education has equipped him with a unique blend of scientific knowledge and regulatory insight, which is essential in today's fast-paced biopharmaceutical sector.
Notable Achievements
- Board Membership: Brad served as a Board Member at Erie International Airport: Tom Ridge Field, contributing his strategic insights to enhance operational efficiencies and promote regional growth.
- Vice Chairman Role: Previously, he held the position of Vice Chairman of the Board at the Anne Arundel Workforce Development Corporation (AAWDC), where he focused on workforce development strategies to ensure that educational programs align with industry needs, particularly in the life sciences.
- Government Relations Expertise: Brad has significant experience in government relations, having served as the Director of Federal Affairs for Maryland Governor Larry Hogan. In this capacity, he provided critical counsel on policies impacting life sciences and biotechnology within the state.
- Consulting Roles: As an Independent Consultant for BioPlan Associates and Kimbles DLS, he provided strategic advice tailored to the needs of various clients in the life sciences domain. His consulting expertise demonstrates his versatility and broad understanding of market dynamics.
- Legislative Advocacy: Brad's early career achievements include serving as Legislative Director for Healthcare & Biotechnology at Delegate Dr. Dan Morhaim, advocating for policies that support innovation and access in healthcare.
Overall, Brad Peganoff's impressive career, marked by extensive experience in government relations and business development within the life sciences, positions him as a leading figure in the biopharmaceutical sector. His dedication to advancing innovative healthcare solutions, combined with a robust educational background and notable achievements, makes him a valuable contributor in addressing some of the most pressing challenges in modern medicine.